Bacillus sp. DU-106 ameliorates type 2 diabetes by modulating gut microbiota in high-fat-fed and streptozotocin-induced mice
Authors:
- 1 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 133 (5) , 3126-3138
Abstract
Aims: Type 2 diabetes (T2D) is a chronic disease that manifests as endocrine and metabolic disorders that seriously threatening public health. This study aimed to investigate the effects of Bacillus sp. DU-106 on anti-diabetic effects and gut microbiota in C57BL/6J mice fed a high-fat diet and streptozotocin-induced T2D. Methods and Results: Bacillus sp. DU-106 was administered to model mice for eight consecutive weeks. Oral administration of Bacillus sp. DU-106 decreased food and water intake and alleviated body weight loss. Moreover, Bacillus sp. DU-106 imparted several health benefits to mice, including balanced blood glucose, alleviation of insulin resistance in T2D mice and an improvement in lipid metabolism. Furthermore, Bacillus sp. DU-106 protected against liver and pancreatic impairment. Additionally, Bacillus sp. DU-106 treatment reshaped intestinal flora by enhancing gut microbial diversity and enriching the abundance of certain functional bacteria. Conclusion: Collectively, these findings suggest that Bacillus sp. DU-106 can ameliorate T2D by regulating the gut microbiota. Significance and Impact of Study: Therefore, a novel probiotic, Bacillus sp. DU-106 may be a promising therapeutic agent for improving and alleviating T2D in mice.Keywords
All Related Versions
Funding Information
- China Agriculture Research System of MOF and MARA (CARS-21)
- Guangzhou Science and Technology Planning Project (202102080487)
- Key-Area Research and Development Program of Guangdong Province (2020B020226008)
- Natural Science Foundation of Guangdong Province (2020A1515011268)
This publication has 61 references indexed in Scilit:
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- Faecalibacterium prausnitzii and human intestinal healthCurrent Opinion in Microbiology, 2013
- Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectivesDiabetes/Metabolism Research and Reviews, 2013
- Probiotic yogurt improves antioxidant status in type 2 diabetic patientsNutrition, 2012
- Oral Antidiabetic Drugs and Regression from Prediabetes to Normoglycemia: A Meta-AnalysisAnnals of Pharmacotherapy, 2012
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- Protective effect of selenium-polysaccharides from the mycelia of Coprinus comatus on alloxan-induced oxidative stress in miceFood Chemistry, 2009
- Sporeformers as Human Probiotics: Bacillus, Sporolactobacillus , and BrevibacillusComprehensive Reviews in Food Science and Food Safety, 2003
- Chronic Hyperglycemia Triggers Loss of Pancreatic β Cell Differentiation in an Animal Model of DiabetesJournal of Biological Chemistry, 1999